CEOINSIDER
Bausch Health logo

Company

Bausch Health

Public · Toronto Stock Exchange: BHCpharmaceutical industryCanada

Bausch Health is a global pharmaceutical company that develops, manufactures and markets branded and generic pharmaceuticals, and over-the-counter products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, and international pharmaceuticals.

Bausch Health is a publicly traded company operating in the pharmaceutical industry sector, based in Canada. It trades on the Toronto Stock Exchange under the ticker BHC. Leadership tracked by CEOInsider includes Joseph C. Papa (CEO).

www.bauschhealth.comLinkedIn ↗

Leadership

Current

Recent developments

AI summary of recent coverage

Recent coverage has focused on Bausch Health's corporate restructuring efforts, including the separation of its Bausch + Lomb subsidiary into a standalone publicly traded company and leadership transitions at the parent organization and its divisions. Headlines also reflect the company's product commercialization activities and regulatory developments across its pharmaceutical and eye care portfolios.

Summarized from the headlines in the sidebar; see each source for the full story.